Financial Architects (New Jersey)’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-149
| Closed | -$1K | – | 1110 |
|
|
2019
Q1 | $1K | Sell |
149
-1
| -0.7% | -$7 | ﹤0.01% | 1233 |
|
|
2018
Q4 | $0 | Sell |
150
-60
| -29% | – | ﹤0.01% | 1223 |
|
|
2018
Q3 | $1K | Hold |
210
| – | – | ﹤0.01% | 1213 |
|
|
2018
Q2 | $2K | Sell |
210
-20
| -9% | -$190 | ﹤0.01% | 1205 |
|
|
2018
Q1 | $8K | Hold |
230
| – | – | ﹤0.01% | 1006 |
|
|
2017
Q4 | $10K | Hold |
230
| – | – | ﹤0.01% | 1016 |
|
|
2017
Q3 | $10K | Buy |
230
+40
| +21% | +$1.74K | ﹤0.01% | 1021 |
|
|
2017
Q2 | $7K | Buy |
190
+14
| +8% | +$516 | ﹤0.01% | 1094 |
|
|
2017
Q1 | $10K | Buy |
176
+96
| +120% | +$5.46K | ﹤0.01% | 1029 |
|
|
2016
Q4 | $4K | Buy |
80
+20
| +33% | +$1K | ﹤0.01% | 1156 |
|
|
2016
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 1154 |
|
|
2016
Q2 | $4K | Buy |
+60
| New | +$4K | ﹤0.01% | 1136 |
|